UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia

Neuropathology, 2006-08, Vol.26 (4), p.307-312

2006

Volltextzugriff (PDF)

Inflammation in peripheral arterial disease (PAD)

Current pharmaceutical design, 2012, Vol.18 (28), p.4350

2012

Volltextzugriff (PDF)

Thrombophilia in Patients With Lower Limb Deep Veins Thrombosis (LDVT) Results of a Monocentric Survey on 103 Consecutive Outpatients

Clinical and applied thrombosis/hemostasis, 2014-09, Vol.20 (6), p.589-593

2014

Volltextzugriff (PDF)

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

Clinical kidney journal, 2022-09, Vol.15 (9), p.1657-1665

2022

Volltextzugriff (PDF)

A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis

Drugs & aging, 2006-01, Vol.23 (3), p.263-270

2006

Volltextzugriff (PDF)

Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study

The American journal of gastroenterology, 2018-03, Vol.113 (3), p.368-375

2018

Volltextzugriff (PDF)

Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study

Angiology, 2016-10, Vol.67 (9), p.870-874

2016

Volltextzugriff (PDF)

Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects

Cytokine (Philadelphia, Pa.), 2012-08, Vol.59 (2), p.294-298

2012

Volltextzugriff (PDF)

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

Journal of endocrinological investigation, 2023-07, Vol.46 (7), p.1429-1439

2023

Volltextzugriff (PDF)

IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

Diabetes therapy, 2022-08, Vol.13 (8), p.1483-1497

2022

Volltextzugriff (PDF)

Study on Unrecognized Peripheral Arterial Disease (PAD) by Ankle/Brachial Index and Arterial Comorbidity in Catania, Sicily, Italy

Angiology, 2010-08, Vol.61 (6), p.524-529

2010

Volltextzugriff (PDF)

Prevalence of high ankle–brachial index (ABI) in general population of Southern Italy, risk factor profiles and systemic cardiovascular co-morbidity: An epidemiological study

Archives of gerontology and geriatrics, 2011-07, Vol.53 (1), p.55-59

2011

Volltextzugriff (PDF)

ICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral artery disease

Vascular medicine (London, England), 2014-06, Vol.19 (3), p.175-181

2014

Volltextzugriff (PDF)

Neopterin: A potential marker in chronic peripheral arterial disease

Molecular medicine reports, 2013-06, Vol.7 (6), p.1855-1858

2013

Volltextzugriff (PDF)

Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients

International journal of molecular medicine, 2011-09, Vol.28 (3), p.437-442

2011

Volltextzugriff (PDF)

Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD

Diabetes research and clinical practice, 2006-06, Vol.72 (3), p.231-237

2006

Volltextzugriff (PDF)

Analysis of interleukin (IL)-1β IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders

Oncology reports, 2006-05, Vol.15 (5), p.1305-1308

2006

Volltextzugriff (PDF)

GLP-1 receptor agonists in the treatment of diabetes mellitus type 2: cardioprotection, and more!

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2021-12, Vol.38 (6)

2021

Volltextzugriff (PDF)

Propionyl-L-Carnitine Therapy: Effects on Endothelin-1 and Homocysteine Levels in Patients with Peripheral Arterial Disease and End-Stage Renal Disease

Kidney & blood pressure research, 2006-08, Vol.29 (2), p.100-107

2006

Volltextzugriff (PDF)

Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders

Oncology reports, 2006-05, Vol.15 (5), p.1305-1308

2006

Volltextzugriff (PDF)

Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2

Vascular pharmacology, 2024-06, Vol.155, p.107329, Article 107329

2024

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(21)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia

Inflammation in peripheral arterial disease (PAD)

Thrombophilia in Patients With Lower Limb Deep Veins Thrombosis (LDVT) Results of a Monocentric Survey on 103 Consecutive Outpatients

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis

Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study

Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study

Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study

Study on Unrecognized Peripheral Arterial Disease (PAD) by Ankle/Brachial Index and Arterial Comorbidity in Catania, Sicily, Italy

Prevalence of high ankle–brachial index (ABI) in general population of Southern Italy, risk factor profiles and systemic cardiovascular co-morbidity: An epidemiological study

ICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral artery disease

Neopterin: A potential marker in chronic peripheral arterial disease

Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients

Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD

Analysis of interleukin (IL)-1β IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders

GLP-1 receptor agonists in the treatment of diabetes mellitus type 2: cardioprotection, and more!

Propionyl-L-Carnitine Therapy: Effects on Endothelin-1 and Homocysteine Levels in Patients with Peripheral Arterial Disease and End-Stage Renal Disease

Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders

Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2

Suchergebnisse filtern